Saturday 17 October 2026
Export MENS’s income statement to Excel — free account
Jyong Biotech Ltd.
MENS Healthcare Biotechnology
1.84
0.14
−7.07%
Follow MENS
| Dec '23 | Dec '24 | Jun '25 | Dec '25 | |
|---|---|---|---|---|
Current Ratio |
0.13 | 0.02 | 0.62 | 0.45 |
Net Debt/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 |
Debt/Assets |
199.95% | 282.12% | 93.06% | 88.76% |
Debt/Equity |
(0.48) | (0.49) | (1.56) | (0.74) |
Operating CF/Net income |
0.00 | 0.00 | — | 0.00 |
Capex/Depreciation |
0.00 | 0.00 | — | 0.00 |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
0.00 | 0.00 | — | 0.00 |
Cash per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Shareholders Equity per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow |
(2.60) | (3.62) | — | (3.04) |
Working Capital |
(12.42) | (11.92) | (10.39) | (19.27) |
Capital Expenditures |
0.00 | 0.00 | — | 0.00 |
Net Current Asset Value |
(40.48) | (42.68) | (42.98) | (30.14) |
| Other line items | ||||
Quick Ratio |
0.12 | 0.01 | 0.62 | 0.03 |
Operating CF per Share |
0.00 | 0.00 | — | 0.00 |
Capex per Share |
0.00 | 0.00 | — | 0.00 |
Capex to Sales |
0.00 | 0.00 | — | 0.00 |
Columns are period end dates